Abstract
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin’s lymphoma with or without antiretroviral therapy during antineoplastic agents
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have